Enliven Therapeutics Inc (ELVN)
17.56
-0.23
(-1.29%)
USD |
NASDAQ |
Apr 30, 15:53
Enliven Therapeutics 1 Year Total Returns (Daily): -6.57% for April 29, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 29, 2024 | -6.57% |
April 26, 2024 | -11.90% |
April 25, 2024 | -14.87% |
April 24, 2024 | -13.11% |
April 23, 2024 | -12.71% |
April 22, 2024 | -11.46% |
April 19, 2024 | -14.79% |
April 18, 2024 | -10.30% |
April 17, 2024 | -6.59% |
April 16, 2024 | 3.66% |
April 15, 2024 | 10.59% |
April 12, 2024 | 10.69% |
April 11, 2024 | 21.90% |
April 10, 2024 | -4.34% |
April 09, 2024 | -10.54% |
April 08, 2024 | -14.69% |
April 05, 2024 | -15.87% |
April 04, 2024 | -18.24% |
April 03, 2024 | -16.07% |
April 02, 2024 | -14.16% |
April 01, 2024 | -13.70% |
March 28, 2024 | -25.12% |
March 27, 2024 | -19.35% |
March 26, 2024 | -23.43% |
March 25, 2024 | -22.70% |
Date | Value |
---|---|
March 22, 2024 | -15.92% |
March 21, 2024 | -17.42% |
March 20, 2024 | -12.48% |
March 19, 2024 | -21.17% |
March 18, 2024 | -43.19% |
March 15, 2024 | -43.78% |
March 14, 2024 | -48.25% |
March 13, 2024 | -43.72% |
March 12, 2024 | -39.54% |
March 11, 2024 | -36.08% |
March 08, 2024 | -33.70% |
March 07, 2024 | -27.32% |
March 06, 2024 | -29.39% |
March 05, 2024 | -27.42% |
March 04, 2024 | -24.57% |
March 01, 2024 | -22.90% |
February 29, 2024 | -25.86% |
February 28, 2024 | -21.08% |
February 27, 2024 | -15.81% |
February 26, 2024 | -26.06% |
February 23, 2024 | -34.61% |
February 22, 2024 | -27.06% |
February 21, 2024 | -24.20% |
February 20, 2024 | -21.25% |
February 16, 2024 | -17.70% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-91.81%
Minimum
Feb 11 2022
403.5%
Maximum
Jun 02 2023
20.24%
Average
-42.76%
Median
1 Year Total Returns (Daily) Benchmarks
Eyenovia Inc | -86.61% |
Phathom Pharmaceuticals Inc | -12.62% |
Lantern Pharma Inc | 0.61% |
Vincerx Pharma Inc | -35.87% |
NKGen Biotech Inc | -- |